Back to
Qube Research & Technologies Ltd
ALT
10 quarters
Position history for
Qube Research & Technologies Ltd's holdings in Altimmune, Inc.
No. Qube Research & Technologies exited its ALT (Altimmune) position in Q4 2023. Its Q3 2023 13F listed 178,697 shares worth $464,612. Qube Research & Technologies first reported ALT in Q3 2020 and held it in 8 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$197,000
Total Shares Change
-14,889
Quarter-by-Quarter History
Other major holders of ALT: State Street Corp., Janus Henderson Group Ltd., BlackRock, Inc., Nuveen Asset Management, LLC